{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Brookhaven",
      "state": "NY",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "93813",
      "recalling_firm": "Amneal Pharmaceuticals of New York, LLC",
      "address_1": "50 Horseblock Rd",
      "address_2": "",
      "postal_code": "11719-9509",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "USA nationwide.",
      "recall_number": "D-0319-2024",
      "product_description": "Phenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottle, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd, Oral Solid Dosage Unit, Ahmedabad 382213, India, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 60219-1502-01",
      "product_quantity": "858 bottles",
      "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specification for unknown impurity.",
      "recall_initiation_date": "20240115",
      "center_classification_date": "20240208",
      "termination_date": "20250131",
      "report_date": "20240214",
      "code_info": "Lot # AM221153, Exp. date 06/30/2024; AM230497, Exp. date 02/29/2025",
      "more_code_info": ""
    }
  ]
}